NLRP3 and metabolic dysfunction-associated steatohepatitis: Meanwhile, in a methionine-choline-deficient diet-induced mouse NASH model, Ang II blocking drugs losartan and perindopril can downregulate expression of NLRP3-related protein and alleviate the liver steatosis.